CompanyGraph
At a glance
- Depends onMidstream position: 5 outgoing, 4 incoming connections
- ScaleMarket cap is $1.8B, above the global median of $1.15B
- FinancialsAltman Z-Score 0.25: distress zone
- Interpretations3 currently firing — 3
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
Financials view
Market Capitalization
1.80BUSDvs all stocks (USD)
Revenue (TTM)
10.53BUSDvs all stocks (USD)
Profit Margin
-11.47%Beta
0.4180xvs all stocks
52-Week Change
-23.58%vs all stocks
Market Capitalization
1.80BUSDvs all stocks (USD)
Enterprise Value
22.30BUSDvs all stocks (USD)
Forward P/E
1.17xPrice to Sales (TTM)
0.1748xEnterprise to Revenue
2.12xEnterprise to EBITDA
6.17xGross Margin
70.76%Profit Margin
-11.47%Operating Margin
20.64%Return on Assets (TTM)
5.93%Revenue (TTM)
10.53BUSDvs all stocks (USD)
Revenue per Share (TTM)
28.33USDUpdated Jul 18, 2026Quarterly Revenue Growth
11.70%Gross Profit (TTM)
7.48BUSDvs all stocks (USD)
EBITDA (TTM)
3.69BUSDvs all stocks (USD)
Net Income (TTM)
-1.21BUSDvs all stocks (USD)
Operating Cash Flow (TTM)
1.42BUSDvs all stocks (USD)
Levered Free Cash Flow (TTM)
1.12BUSDvs all stocks (USD)
5-Year Average Dividend Yield
6.52%vs all stocks
Payout Ratio
0.00%Minority Interest (Equity)
931.00MUSDFY2025 · Dec 31, 2025Revenue
10.27BUSDFY2025 · Dec 31, 2025Cost of Goods Sold
3.01BUSDFY2025 · Dec 31, 2025Gross Profit
7.25BUSDFY2025 · Dec 31, 2025Operating Income
2.19BUSDvs all stocks (USD)
Pre-tax Income
367.00MUSDFY2025 · Dec 31, 2025Income Tax Expense
247.00MUSDFY2025 · Dec 31, 2025Net Income
120.00MUSDFY2025 · Dec 31, 2025EBIT
1.97BUSDFY2025 · Dec 31, 2025EBITDA (Income Statement)
3.44BUSDFY2025 · Dec 31, 2025Research & Development
629.00MUSDFY2025 · Dec 31, 2025Selling, General & Administrative
3.44BUSDFY2025 · Dec 31, 2025Non-operating Interest Income
48.00MUSDFY2025 · Dec 31, 2025Non-operating Interest Expense
1.60BUSDFY2025 · Dec 31, 2025Net Income from Continuing Operations
120.00MUSDFY2025 · Dec 31, 2025Minority Interests (P&L)
37.00MUSDFY2025 · Dec 31, 2025Operating Cash Flow
1.36BUSDFY2025 · Dec 31, 2025Free Cash Flow
965.00MUSDFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
1.32BUSDFY2025 · Dec 31, 2025Income Tax Paid
163.00MUSDFY2025 · Dec 31, 2025Interest Paid
1.81BUSDFY2025 · Dec 31, 2025Starting Profit (CF Statement)
120.00MUSDFY2025 · Dec 31, 2025Depreciation & Amortization
1.21BUSDFY2025 · Dec 31, 2025Deferred Taxes (CF)
80.00MUSDFY2025 · Dec 31, 2025Stock-based Compensation
216.00MUSDFY2025 · Dec 31, 2025Other Non-cash Items
-40.00MUSDFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-134.00MUSDFY2025 · Dec 31, 2025Change in Accounts Payable (CF)
-76.00MUSDFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-12.00MUSDFY2025 · Dec 31, 2025Capital Expenditures
-397.00MUSDFY2025 · Dec 31, 2025Net Intangibles (CF)
-10.00MUSDFY2025 · Dec 31, 2025Net Acquisitions
-204.00MUSDFY2025 · Dec 31, 2025Purchase of Investments
-11.00MUSDFY2025 · Dec 31, 2025Sale of Investments
8.00MUSDFY2025 · Dec 31, 2025Other Investing Activity
7.00MUSDFY2025 · Dec 31, 2025Net Investing Cash Flow
-597.00MUSDFY2025 · Dec 31, 2025Long-term Debt Issuance
10.55BUSDFY2025 · Dec 31, 2025Long-term Debt Payments
-11.19BUSDFY2025 · Dec 31, 2025Other Financing Charges
-105.00MUSDFY2025 · Dec 31, 2025Net Financing Cash Flow
-742.00MUSDFY2025 · Dec 31, 2025Shares Outstanding
373.46MSharesUpdated Jul 18, 2026Float Shares
259.99MSharesUpdated Jul 18, 2026Shares Short
7.33MSharesUpdated Jul 18, 2026Short Ratio
2.43daysvs all stocks
Short % of Shares Outstanding
2.46%vs all stocks
% Held by Insiders
11.14%vs all stocks
% Held by Institutions
65.02%vs all stocks
Total Cash (MRQ)
1.30BUSDvs all stocks (USD)
Total Cash per Share (MRQ)
3.48USDUpdated Jul 18, 2026Total Debt (MRQ)
20.80BUSDvs all stocks (USD)
Current Ratio (MRQ)
1.32xBook Value per Share (MRQ)
-5.51USDUpdated Jul 18, 2026Total Assets
26.37BUSDvs all stocks (USD)
Total Current Assets
6.16BUSDFY2025 · Dec 31, 2025Total Liabilities
25.99BUSDFY2025 · Dec 31, 2025Total Non-current Assets
20.21BUSDFY2025 · Dec 31, 2025Total Non-current Liabilities
21.81BUSDFY2025 · Dec 31, 2025Total Current Liabilities
4.18BUSDFY2025 · Dec 31, 2025Cash & Cash Equivalents
1.31BUSDFY2025 · Dec 31, 2025Accounts Receivable
2.35BUSDFY2025 · Dec 31, 2025Inventory
1.63BUSDFY2025 · Dec 31, 2025Accounts Payable
600.00MUSDFY2025 · Dec 31, 2025Short-term Debt
236.00MUSDFY2025 · Dec 31, 2025Other Current Liabilities
999.00MUSDFY2025 · Dec 31, 2025Long-term Debt
20.61BUSDFY2025 · Dec 31, 2025Other Non-current Liabilities
1.05BUSDFY2025 · Dec 31, 2025Common Stock (Book)
10.52BUSDFY2025 · Dec 31, 2025Retained Earnings
-9.67BUSDFY2025 · Dec 31, 2025Total Shareholders' Equity
377.00MUSDvs all stocks (USD)
52-Week Low
4.57USDUpdated Jul 18, 202652-Week High
8.69USDUpdated Jul 18, 202652-Week Change
-23.58%vs all stocks
Beta
0.4180xvs all stocks
50-Day MA
5.15USDUpdated Jul 18, 2026200-Day MA
5.93USDUpdated Jul 18, 2026Avg 10-Day Volume
1.76MSharesUpdated Jul 18, 2026Avg 30-Day Volume
2.60MSharesUpdated Jul 18, 2026Diluted EPS (TTM)
-3.24USDUpdated Jul 18, 2026Other Income / Expense
-262.00MUSDFY2025 · Dec 31, 20253 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsHow is this stock valued?
Drawdown With FCF And Cash Backing
Well below its peak, with three years of positive free cash flow behind it.
Reads
Where is this company structurally exposed?
Within or Near the Altman Distress Zone
Debt is a large share of its assets, and large against its cash flow.
Reads
Ulcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
It sits well below its peak, and the fall has been both deep and long.
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Structural Tensions
High gross margins eroded by operating costsNotable
Gross Margin: 0.71Profit Margin: -0.11
Financial Health
Altman Z-Score 0.25: distress zoneCritical
Altman Z-Score: 0.25
Supply Chain
Midstream position: 5 outgoing, 4 incoming connectionsNotable
Outgoing: 5.00Incoming: 4.00
Scale
Market cap is $1.8B, above the global median of $1.15BNotable
Market cap (USD): 1,803,887,360Global Median: 1,146,734,693.424
Revenue is $10.53B, above the global median of $520.53MNotable
Revenue (USD): 10,531,000,320Global Median: 520,528,949.311
Levered free cash flow is $1.12B, above the global median of $16.24MNotable
Levered free cash flow (USD): 1,123,500,032Global Median: 16,239,329.704
Companies that share the same coordination system — how they create, deliver, or capture value.
Ani Pharmaceuticals Inc.
Tier 1ProductionApproval-Gated PipelineRule
Stoke Therapeutics Inc.
Tier 1ProductionApproval-Gated PipelineRule
PolyPeptide Group AG
Tier 1ProductionApproval-Gated PipelineRuleFlow
Chengdu Olymvax Biopharmaceuticals Inc.
Tier 1ProductionApproval-Gated PipelineRule
Sarepta Therapeutics Inc.
Tier 1ProductionApproval-Gated PipelineRule
BeBetter Med Inc.
Tier 1ProductionApproval-Gated PipelineRuleRisk
Bicara Therapeutics Inc.
Tier 1ProductionApproval-Gated PipelineRule
D&D Pharmatech Inc.
Tier 1ProductionApproval-Gated PipelineRuleRisk
Zymeworks Inc.
Tier 1ProductionApproval-Gated PipelineRule
Heron Neutron Medical Corp.
Tier 1ProductionApproval-Gated PipelineRule
Companies that share active interpretations — structural patterns currently present in both stocks.
Gogo Inc.
3 interpretationsWithin or Near the Altman Distress ZoneUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility ElevatedDrawdown With FCF And Cash Backing
Rapid7 Inc.
3 interpretationsWithin or Near the Altman Distress ZoneUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility ElevatedDrawdown With FCF And Cash Backing
Verra Mobility Corporation
3 interpretationsWithin or Near the Altman Distress ZoneUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility ElevatedDrawdown With FCF And Cash Backing